Panbela Therapeutics, Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The firm’s product candidate, SBP-101, is a proprietary polyamine analogue designed to induce polyamine metabolic inhibition (PMI), a metabolic pathway of critical importance in multiple tumor types. The company was founded by Michael T. Cullen, Jr. and Thomas X. Neenan on September 21, 2011 and is headquartered in Waconia, MN.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Panbela Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Panbela Therapeutics Inc. market cap is $97,600.00.
What is the 52-week high for Panbela Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Panbela Therapeutics Inc. 52 week high is $0.4729 as of October 19, 2025.
What is the 52-week low for Panbela Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Panbela Therapeutics Inc. 52 week low is $0.0002 as of October 19, 2025.
What is Panbela Therapeutics Inc. stock price today?
Panbela Therapeutics Inc. stock price today is $0.0201.
What was Panbela Therapeutics Inc. stock price yesterday?
Panbela Therapeutics Inc. stock price yesterday was $0.011.
What is the PE ratio of Panbela Therapeutics Inc.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Panbela Therapeutics Inc.’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Panbela Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Panbela Therapeutics Inc. P/B ratio is -0.0054.
What is the 50-day moving average of Panbela Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Panbela Therapeutics Inc. 50-day moving average is $0.0823.
